Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity
Tomoko Ikeda(Tohoku University), Hideo Harigae(Tohoku University Hospital), Tsuyoshi Shirai(Tohoku University), Yuko Shirota(Tohoku University), Yukiko Kamogawa(Tohoku University), Masato Nose(Meiji University), Tomonori Ishii(Tohoku University)
Cited by 12
Related Papers
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
|Immunity|1999|2.7k
The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
|The Journal of Experimental Medicine|2016|534
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523
Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion
|Proceedings of the National Academy of Sciences|2002|398